Malignant pheochromocytoma imaging with [124I]mIBG PET/MR

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3833-3834

  Hartung Knemeyer, Verena ^a   Rosenbaum Krumme, Sandra ^a   Buchbender, Christian ^c   Pop̈pel, Thorsten ^a   Brandau, Wolfgang ^a   Jentzen, Walter ^a   Antoch, Gerald ^c   Forsting, Michael ^b   Bockisch, Andreas ^a   K̈uhl, Hilmar ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UniversityHospital Essen ^*  (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 124; (3 IODOBENZYL)GUANIDINE I 131; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DOSIMETRY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MUSCLE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM METASTASIS; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT PLANNING; WHOLE BODY PET;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; FEMALE; HUMANS; PHEOCHROMOCYTOMA; YOUNG ADULT;

EID: 84868628408     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1958     Document Type: Short Survey

References (3)

1. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB 2007 The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer 14:569-585 (Pubitemid 350074048)
2. Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A 2010 131I/123I-Metaiodobenzyl-guanidine (mIBG) scintigraphy-procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 37:2436-2446
3. Ott RJ, Tait D, Flower MA, Babich JW, LambrechtRM 1992 Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography. Br J Radiol 65:787-791